TrialAmerican heart journal2017

Lisinopril or Coreg CR in reducing cardiotoxicity in women with breast cancer receiving trastuzumab: A rationale and design of a randomized clinical trial.

Maya Guglin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.